SCHEMBL13627918

SCHEMBL13627918

CC(=O)N(C)c1cnccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
NAPRT Q6XQN6 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
LMNA P02545 2/20 0.40
GAA P10253 2/20 0.40
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TSHR P16473 2/20 0.39
ADORA3 P0DMS8 1/20 0.39
MC4R P32245 1/20 0.39
ADRA1A P35348 1/20 0.39
MC3R P41968 1/20 0.39
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HDAC6 Q9UBN7 1/20 0.35
HSD17B10 Q99714 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30227483 1.00 KDM4E (0.50) KDM4EALDH1A1CYP1A2POLBNAPRT
SCHEMBL1933894 0.84 POLB (0.50) KDM4EALDH1A1CYP1A2POLBNAPRT
SCHEMBL28519924 0.82 POLB (0.49) KDM4EALDH1A1CYP1A2POLBNAPRT
SCHEMBL1265669 0.75 POLB (0.42) KDM4EALDH1A1CYP1A2POLBNAPRT
Ampyzine SCHEMBL30627403 0.73
SCHEMBL13367380 0.73 POLB (0.55) KDM4EALDH1A1CYP1A2POLBNAPRT
Ampyzine SCHEMBL160265 0.73
SCHEMBL19972911 0.73 POLB (0.47) KDM4EALDH1A1CYP1A2POLBNAPRT
Ampyzine SCHEMBL122178 0.72 POLB (0.50) KDM4EALDH1A1CYP1A2POLBNAPRT
SCHEMBL762423 0.72 ALDH1A1 (0.50) KDM4EALDH1A1POLBNAPRTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619092-B2 Piperidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-11-17 US disclosed
US-7619092-B2 Piperidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-11-17 US disclosed